{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:12:40Z","timestamp":1790993560451,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,17]]},"DOI":"10.7759\/cureus.75859","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T10:39:37Z","timestamp":1734431977000},"source":"Crossref","is-referenced-by-count":5,"title":["The Pathogenesis and Management of Vitiligo"],"prefix":"10.7759","author":[{"given":"Lama M","family":"Albelowi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rema M","family":"Alhazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Vitiligo","author":"Ahmed jan N","year":"2023","unstructured":"Ahmed jan N, Masood S. Vitiligo. StatPearls Publishing, Treasure Island, USA; 2023."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s13671-014-0098-6","article-title":"The epidemiology of vitiligo","volume":"4","author":"Silverberg NB","year":"2015","unstructured":"Silverberg NB. The epidemiology of vitiligo. Curr Derm Rep. 2015, 4:36-43. 10.1007\/s13671-014-0098-6","journal-title":"Curr Derm Rep"},{"key":"ref3","article-title":"Beyond traditional treatment: the importance of psychosocial therapy in vitiligo","volume":"17","author":"Rzepecki AK","year":"2018","unstructured":"Rzepecki AK, McLellan BN, Elbuluk N. Beyond traditional treatment: the importance of psychosocial therapy in vitiligo. J Drugs Dermatol. 2018, 17:688-91.","journal-title":"J Drugs Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2020.05.007","article-title":"Consensus on the treatment of vitiligo - Brazilian Society of Dermatology","volume":"95","author":"Dellatorre G","year":"2020","unstructured":"Dellatorre G, Antelo DA, Bedrikow RB, Cestari TF, Follador I, Ramos DG, Silva de Castro CC. Consensus on the treatment of vitiligo - Brazilian Society of Dermatology. An Bras Dermatol. 2020, 95:70-82. 10.1016\/j.abd.2020.05.007","journal-title":"An Bras Dermatol"},{"key":"ref5","article-title":"Vitiligo-epidemiological study of 4134 patients at the National Center for Vitiligo and Psoriasis in Central Saudi Arabia","volume":"32","author":"Alissa A","year":"2011","unstructured":"Alissa A, Al Eisa A, Huma R, Mulekar S. Vitiligo-epidemiological study of 4134 patients at the National Center for Vitiligo and Psoriasis in Central Saudi Arabia. Saudi Med J. 2011, 32:1291-6.","journal-title":"Saudi Med J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jssdds.2013.12.001","article-title":"The clinical patterns of vitiligo \"hospital-based study\" in Makkah region, Saudi Arabia","volume":"18","author":"Fatani MI","year":"2014","unstructured":"Fatani MI, AlSharif SH, Alfif KA, Khan AS, Hussain WA, Banjar AA. The clinical patterns of vitiligo \"hospital-based study\" in Makkah region, Saudi Arabia. J Dermatol Dermatol Surg. 2014, 18:17-21. 10.1016\/j.jssdds.2013.12.001","journal-title":"J Dermatol Dermatol Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20142717","article-title":"Vitiligo-part 2-classification, histopathology and treatment","volume":"89","author":"Faria AR","year":"2014","unstructured":"Faria AR, Tarl\u00e9 RG, Dellatorre G, Mira MT, Silva de Castro CC. Vitiligo-part 2-classification, histopathology and treatment. An Bras Dermatol. 2014, 89:784-90. 10.1590\/abd1806-4841.20142717","journal-title":"An Bras Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsi.2016.07.001","article-title":"Nonsegmental vitiligo update","volume":"34","author":"Furue M","year":"2016","unstructured":"Furue M, Kadono T. Nonsegmental vitiligo update. Dermatol Sin. 2016, 34:173-6. 10.1016\/j.dsi.2016.07.001","journal-title":"Dermatol Sin"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12878","article-title":"The enigma and challenges of vitiligo pathophysiology and treatment","volume":"33","author":"Abdel-Malek ZA","year":"2020","unstructured":"Abdel-Malek ZA, Jordan C, Ho T, Upadhyay PR, Fleischer A, Hamzavi I. The enigma and challenges of vitiligo pathophysiology and treatment. Pigment Cell Melanoma Res. 2020, 33:778-87. 10.1111\/pcmr.12878","journal-title":"Pigment Cell Melanoma Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/2349-5847.219673","article-title":"Pathogenesis of vitiligo: an update","volume":"4","author":"Arora AK","year":"2017","unstructured":"Arora AK, Kumaran MS. Pathogenesis of vitiligo: an update. Pigment Int. 2017, 4:65-77. 10.4103\/2349-5847.219673","journal-title":"Pigment Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2011.11.019","article-title":"Investigating the role of melanin in UVA\/UVB- and hydrogen peroxide-induced cellular and mitochondrial ROS production and mitochondrial DNA damage in human melanoma cells","volume":"52","author":"Swalwell H","year":"2012","unstructured":"Swalwell H, Latimer J, Haywood RM, Birch-Machin MA. Investigating the role of melanin in UVA\/UVB- and hydrogen peroxide-induced cellular and mitochondrial ROS production and mitochondrial DNA damage in human melanoma cells. Free Radic Biol Med. 2012, 52:626-34. 10.1016\/j.freeradbiomed.2011.11.019","journal-title":"Free Radic Biol Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v3.i3.221","article-title":"Highlights in pathogenesis of vitiligo","volume":"3","author":"Mohammed GF","year":"2015","unstructured":"Mohammed GF, Gomaa AH, Al-Dhubaibi MS. Highlights in pathogenesis of vitiligo. World J Clin Cases. 2015, 3:221-30. 10.12998\/wjcc.v3.i3.221","journal-title":"World J Clin Cases"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2016.11.014","article-title":"Vitiligo pathogenesis and emerging treatments","volume":"35","author":"Rashighi M","year":"2017","unstructured":"Rashighi M, Harris JE. Vitiligo pathogenesis and emerging treatments. Dermatol Clin. 2017, 35:257-65. 10.1016\/j.det.2016.11.014","journal-title":"Dermatol Clin"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.16","article-title":"Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy","volume":"131","author":"van den Boorn JG","year":"2011","unstructured":"van den Boorn JG, Picavet DI, van Swieten PF, et al.. Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy. J Invest Dermatol. 2011, 131:1240-51. 10.1038\/jid.2011.16","journal-title":"J Invest Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051040","article-title":"Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin","volume":"7","author":"Yu R","year":"2012","unstructured":"Yu R, Broady R, Huang Y, et al.. Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin. PLoS One. 2012, 7:e51040. 10.1371\/journal.pone.0051040","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-011-0752-2","article-title":"miR-27b*, an oxidative stress-responsive microRNA modulates nuclear factor-kB pathway in RAW 264.7 cells","volume":"352","author":"Thulasingam S","year":"2011","unstructured":"Thulasingam S, Massilamany C, Gangaplara A, et al.. miR-27b*, an oxidative stress-responsive microRNA modulates nuclear factor-kB pathway in RAW 264.7 cells. Mol Cell Biochem. 2011, 352:181-8. 10.1007\/s11010-011-0752-2","journal-title":"Mol Cell Biochem"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2014.09.003","article-title":"Mitochondrial DNA acquires immunogenicity on exposure to nitrosative stress in patients with vitiligo","volume":"75","author":"Al-Shobaili HA","year":"2014","unstructured":"Al-Shobaili HA, Rasheed Z. Mitochondrial DNA acquires immunogenicity on exposure to nitrosative stress in patients with vitiligo. Hum Immunol. 2014, 75:1053-61. 10.1016\/j.humimm.2014.09.003","journal-title":"Hum Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.328","article-title":"Activation of the unfolded protein response in vitiligo: the missing link?","volume":"132","author":"Passeron T","year":"2012","unstructured":"Passeron T, Ortonne JP. Activation of the unfolded protein response in vitiligo: the missing link?. J Invest Dermatol. 2012, 132:2502-4. 10.1038\/jid.2012.328","journal-title":"J Invest Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1159\/000506103","article-title":"Vitiligo: a review","volume":"236","author":"Bergqvist C","year":"2020","unstructured":"Bergqvist C, Ezzedine K. Vitiligo: a review. Dermatology. 2020, 236:571-92. 10.1159\/000506103","journal-title":"Dermatology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3005127","article-title":"Mutant HSP70 reverses autoimmune depigmentation in vitiligo","volume":"5","author":"Mosenson JA","year":"2013","unstructured":"Mosenson JA, Zloza A, Nieland JD, et al.. Mutant HSP70 reverses autoimmune depigmentation in vitiligo. Sci Transl Med. 2013, 5:174ra28. 10.1126\/scitranslmed.3005127","journal-title":"Sci Transl Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.06.186","article-title":"HSP70i(Q435A)-encoding DNA repigments vitiligo lesions in Sinclair swine","volume":"138","author":"Henning SW","year":"2018","unstructured":"Henning SW, Fernandez MF, Mahon JP, et al.. HSP70i(Q435A)-encoding DNA repigments vitiligo lesions in Sinclair swine. J Invest Dermatol. 2018, 138:2531-9. 10.1016\/j.jid.2018.06.186","journal-title":"J Invest Dermatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.01.004","article-title":"The role of IL-17 in vitiligo: a review","volume":"15","author":"Singh RK","year":"2016","unstructured":"Singh RK, Lee KM, Vujkovic-Cvijin I, et al.. The role of IL-17 in vitiligo: a review. Autoimmun Rev. 2016, 15:397-404. 10.1016\/j.autrev.2016.01.004","journal-title":"Autoimmun Rev"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12355","article-title":"Increased circulating Th17 cells and elevated serum levels of TGF-beta and IL-21 are correlated with human non-segmental vitiligo development","volume":"28","author":"Zhou L","year":"2015","unstructured":"Zhou L, Shi YL, Li K, et al.. Increased circulating Th17 cells and elevated serum levels of TGF-beta and IL-21 are correlated with human non-segmental vitiligo development. Pigment Cell Melanoma Res. 2015, 28:324-9. 10.1111\/pcmr.12355","journal-title":"Pigment Cell Melanoma Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2016.12.014","article-title":"Increased systemic and epidermal levels of IL-17A and IL-1\u03b2 promotes progression of non-segmental vitiligo","volume":"91","author":"Bhardwaj S","year":"2017","unstructured":"Bhardwaj S, Rani S, Srivastava N, Kumar R, Parsad D. Increased systemic and epidermal levels of IL-17A and IL-1\u03b2 promotes progression of non-segmental vitiligo. Cytokine. 2017, 91:153-61. 10.1016\/j.cyto.2016.12.014","journal-title":"Cytokine"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s41702-018-0030-y","article-title":"Exploring vitiligo susceptibility and management: a brief review","volume":"2","author":"Rahman R","year":"2018","unstructured":"Rahman R, Hasija Y. Exploring vitiligo susceptibility and management: a brief review. Biomed dermatol. 2018, 2:20. 10.1186\/s41702-018-0030-y","journal-title":"Biomed dermatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2014.02.006","article-title":"Recent advances in childhood vitiligo","volume":"32","author":"Silverberg NB","year":"2014","unstructured":"Silverberg NB. Recent advances in childhood vitiligo. Clin Dermatol. 2014, 32:524-30. 10.1016\/j.clindermatol.2014.02.006","journal-title":"Clin Dermatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.12.007","article-title":"Combination treatment of non-segmental vitiligo with a 308-nm xenon chloride excimer laser and topical high-concentration tacalcitol: a prospective, single-blinded, paired, comparative study","volume":"65","author":"Oh SH","year":"2011","unstructured":"Oh SH, Kim T, Jee H, Do JE, Lee JH. Combination treatment of non-segmental vitiligo with a 308-nm xenon chloride excimer laser and topical high-concentration tacalcitol: a prospective, single-blinded, paired, comparative study. J Am Acad Dermatol. 2011, 65:428-30. 10.1016\/j.jaad.2010.12.007","journal-title":"J Am Acad Dermatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2016.11.006","article-title":"Chemical-induced vitiligo","volume":"35","author":"Harris JE","year":"2017","unstructured":"Harris JE. Chemical-induced vitiligo. Dermatol Clin. 2017, 35:151-61. 10.1016\/j.det.2016.11.006","journal-title":"Dermatol Clin"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S76088","article-title":"The psychosocial impact of acne, vitiligo, and psoriasis: a review","volume":"9","author":"Nguyen CM","year":"2016","unstructured":"Nguyen CM, Beroukhim K, Danesh MJ, Babikian A, Koo J, Leon A. The psychosocial impact of acne, vitiligo, and psoriasis: a review. Clin Cosmet Investig Dermatol. 2016, 9:383-92. 10.2147\/CCID.S76088","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref30","article-title":"Beyond traditional treatment: the importance of psychosocial therapy in vitiligo","volume":"17","author":"Rzepecki AK","year":"2018","unstructured":"Rzepecki AK, McLellan BN, Elbuluk N. Beyond traditional treatment: the importance of psychosocial therapy in vitiligo. Journal of drugs in dermatology: JDD. 2018, 17:688-91.","journal-title":"Journal of drugs in dermatology: JDD"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-69361-1_40","article-title":"Vitamin D analogues","author":"Picardo M","year":"2010","unstructured":"Picardo M. Vitamin D analogues. Vitiligo.  Picardo M, Ta\u00efeb A (ed): Springer, Berlin; 2010. 339-42. 10.1007\/978-3-540-69361-1_40"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1590\/s0365-05962013000100009","article-title":"Mechanisms regulating melanogenesis","volume":"88","author":"Videira IF","year":"2013","unstructured":"Videira IF, Moura DF, Magina S. Mechanisms regulating melanogenesis. An Bras Dermatol. 2013, 88:76-83. 10.1590\/s0365-05962013000100009","journal-title":"An Bras Dermatol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60763-7","article-title":"Vitiligo","volume":"386","author":"Ezzedine K","year":"2015","unstructured":"Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. Lancet. 2015, 386:74-84. 10.1016\/S0140-6736(14)60763-7","journal-title":"Lancet"},{"key":"ref34","article-title":"The mechanisms of action of phototherapy in the treatment of the most common dermatoses","volume":"35","author":"Bulat V","year":"2011","unstructured":"Bulat V, Situm M, Dediol I, Ljubici\u0107 I, Bradi\u0107 L . The mechanisms of action of phototherapy in the treatment of the most common dermatoses. Coll Antropol. 2011, 35:147-51.","journal-title":"Coll Antropol"},{"key":"ref35","article-title":"A review and update on melanocyte stimulating hormone therapy: afamelanotide","volume":"12","author":"Fabrikant J","year":"2013","unstructured":"Fabrikant J, Touloei K, Brown SM. A review and update on melanocyte stimulating hormone therapy: afamelanotide. J Drugs Dermatol. 2013, 12:775-9.","journal-title":"J Drugs Dermatol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2014.1875","article-title":"Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial","volume":"151","author":"Lim HW","year":"2015","unstructured":"Lim HW, Grimes PE, Agbai O, et al.. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial. JAMA Dermatol. 2015, 151:42-50. 10.1001\/jamadermatol.2014.1875","journal-title":"JAMA Dermatol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.2011.00606.x","article-title":"Photo(chemo)therapy for vitiligo","volume":"27","author":"Pacifico A","year":"2011","unstructured":"Pacifico A, Leone G. Photo(chemo)therapy for vitiligo. Photodermatol Photoimmunol Photomed. 2011, 27:261-77. 10.1111\/j.1600-0781.2011.00606.x","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"ref38","doi-asserted-by":"crossref","DOI":"10.3329\/fmcj.v12i1.33489","article-title":"Vitiligo management-an update","volume":"12","author":"Sarkar SK","year":"2017","unstructured":"Sarkar SK, Sen KG, Mostofa MK. Vitiligo management-an update. Faridpur Med Coll J. 2017, 12:34-9.","journal-title":"Faridpur Med Coll J"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1940","article-title":"Hidden victims of childhood vitiligo: impact on parents' mental health and quality of life","volume":"95","author":"Amer AA","year":"2015","unstructured":"Amer AA, Mchepange UO, Gao XH, et al.. Hidden victims of childhood vitiligo: impact on parents' mental health and quality of life. Acta Derm Venereol. 2015, 95:322-5. 10.2340\/00015555-1940","journal-title":"Acta Derm Venereol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13517","article-title":"Therapeutic interventions to lessen the psychosocial effect of vitiligo in children: a review","volume":"35","author":"Cadmus SD","year":"2018","unstructured":"Cadmus SD, Lundgren AD, Ahmed AM. Therapeutic interventions to lessen the psychosocial effect of vitiligo in children: a review. Pediatr Dermatol. 2018, 35:441-7. 10.1111\/pde.13517","journal-title":"Pediatr Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/326304-the-pathogenesis-and-management-of-vitiligo","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T10:39:39Z","timestamp":1734431979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/326304-the-pathogenesis-and-management-of-vitiligo"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,17]]},"references-count":40,"URL":"https:\/\/doi.org\/10.7759\/cureus.75859","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,17]]}}}